FindTrial
Sign In

Treatment Efficacy for Drug Abuse and AIDS Prevention - 1

Treatment Efficacy for Drug Abuse and AIDS Prevention

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000210
Enrollment
0
Registered
1999-09-21
Start date
1989-09-30
Completion date
1996-02-29
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders, Heroin Dependence

Keywords

opioid addiction, cocaine addiction

Brief summary

The purpose of this study is to assess the safety and effectiveness of buprenorphine for treatment of concurrent intravenous heroin and cocaine dependence.

Interventions

DRUGBuprenorphine

Sponsors

Mclean Hospital
CollaboratorOTHER
National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
MALE
Age
26 Years to 41 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026